- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kilitch Drugs India Ltd (KIDI)
Kilitch Drugs India Ltd stock price live, this page displays NSE KIDI stock exchange data. View the KIDI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kilitch Drugs India Ltd real time stock price chart below.
What Is the Kilitch Drugs India Ltd Stock Price Today?
The Kilitch Drugs India Ltd stock price today is 448.80.
What Is the Stock Symbol for Kilitch Drugs India Ltd?
The stock symbol for Kilitch Drugs India Ltd is ""KIDI.""
What Stock Exchange Does Kilitch Drugs India Ltd Trade On?
Kilitch Drugs India Ltd is listed and trades on the NSE stock exchange.
Is Kilitch Drugs India Ltd a Good Stock to Buy?
Determining whether Kilitch Drugs India Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KIDI quote. (ISIN: INE729D01010)
What Is the Kilitch Drugs India Ltd Stock Price Today?
The Kilitch Drugs India Ltd stock price today is 448.80.
What Is the Stock Symbol for Kilitch Drugs India Ltd?
The stock symbol for Kilitch Drugs India Ltd is ""KIDI.""
What Stock Exchange Does Kilitch Drugs India Ltd Trade On?
Kilitch Drugs India Ltd is listed and trades on the NSE stock exchange.
Is Kilitch Drugs India Ltd a Good Stock to Buy?
Determining whether Kilitch Drugs India Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KIDI quote. (ISIN: INE729D01010)
448.80
+8.80(+2.00%)
Closed·
Fair Value
An estimate of a Kilitch Drugs India Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
435.30
448.80
52 wk Range
299.95
500.00
KIDI Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
KIDI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Kilitch Drugs India Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
435.30448.80
52 wk Range
299.95500.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
KIDI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Kilitch Drugs India Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Kilitch Drugs India Ltd Company Profile
Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, non-steroidal anti-inflammatory, anticonvulsant/antiepileptic, anti-inflammatory, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, antifungals, corticosteroids, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops, as well as Klavmox and Onecef products. The company also provides a range of oral formulations, including tablets, soft gelatin capsules, dry syrup, gripe water, and oral gel, powder, and liquid in the cardiovascular and anti-diabetics areas. In addition, it offers effervescent tablets and powders, such as ROIPAR, DUREGRA, and ROIVIT; and various nutritional products, such as CELTINE. Further, the company provides C-Seal, a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally, it offers cosmetics and herbal products consisting of a range of oils, creams, lotions, liquids, and paste in skin, personal, and hair care categories, as well as herbal products used in sore throat and prostate problems; and as a supplement for diabetes, obesity, libido, and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India.
Compare KIDI to Peers and Sector
Metrics to compare | KIDI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKIDIPeersSector | |
|---|---|---|---|---|
P/E Ratio | 27.0x | 5.5x | −0.5x | |
PEG Ratio | 0.33 | 0.14 | 0.00 | |
Price/Book | 3.6x | 1.2x | 2.6x | |
Price / LTM Sales | 3.6x | 1.1x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 43.4% | |
Fair Value Upside | Unlock | 14.3% | 7.1% | Unlock |
Earnings
Latest Release
May 19, 2025
EPS / Forecast
6.47 / --
Revenue / Forecast
629.23M / --
People Also Watch
FAQ
What Stock Exchange Does Kilitch Drugs India Ltd Trade On?
Kilitch Drugs India Ltd is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Kilitch Drugs India Ltd?
The stock symbol for Kilitch Drugs India Ltd is "KIDI."
What Is the Kilitch Drugs India Ltd Market Cap?
As of today, Kilitch Drugs India Ltd market cap is 7.22B.
What Is Kilitch Drugs India Ltd's Earnings Per Share (TTM)?
The Kilitch Drugs India Ltd EPS (TTM) is 16.60.
From a Technical Analysis Perspective, Is KIDI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Kilitch Drugs India Ltd Stock Split?
Kilitch Drugs India Ltd has split 0 times.
How Many Employees Does Kilitch Drugs India Ltd Have?
Kilitch Drugs India Ltd has 168 employees.
What is the current trading status of Kilitch Drugs India Ltd (KIDI)?
As of 10 Aug 2025, Kilitch Drugs India Ltd (KIDI) is trading at a price of 448.80, with a previous close of 440.00. The stock has fluctuated within a day range of 435.30 to 448.80, while its 52-week range spans from 299.95 to 500.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.